TABLE 1.
Patient and Disease Characteristics
| Characteristic | UCD (n=18) |
HHV8 negative MCD (n=6) |
|---|---|---|
| N (%) or Median (IQR) | ||
| Sex | ||
| Female | 8 (44%) | 1 (17%) |
| Male | 10 (56%) | 5 (83%) |
| Age (years) | 13.2 (9.4, 15.7) (range: 4.9–18.4) |
10.8 (4.8, 14.3) (range: 1.8–14.7) |
| Ethnicity | ||
| Hispanic | 2 (11%) | 1 (17%) |
| Non-Hispanic | 14 (78%) | 5 (83%) |
| Unknown | 2 (11%) | 0 (0%) |
| Race | ||
| Black or African American | 1 (6%) | 0 (0%) |
| White | 14 (82%) | 5 (83%) |
| Hispanic | 1 (6%) | 0 (0%) |
| Other | 1 (6%) | 1 (17%) |
| Pathologic diagnosis | ||
| Hyaline vascular | 14 (78%) | 4 (67%) |
| Plasma Cell Variant | 3 (17%) | 2 (33%) |
| Mixed | 1 (6%) | 0 (0%) |
| Primary disease site | ||
| Head/Neck | 8 (44%) | 1 (17%) |
| Chest | 2 (11%) | 1 (17%) |
| Abdomen | 5 (28%) | 0 (0%) |
| Pelvis | 0 (0%) | 2 (33%) |
| Extremity | 1 (6%) | 1 (17%) |
| Diffuse lymphadenopathy | 0 (0%) | 1 (17%) |
| Other | 2 (11%) | 0 (0%) |
| Systemic symptoms | 8 (44%) | 4 (67%) |
No patients in this cohort had HHV8-positive MCD